Seattle biotech BrainChild Bio has raised $116 million to advance an experimental CAR T cell therapy for DIPG, a rare and ...

Collaboration pairs Massive Bio's AI trial matching and concierge support with PrecisCa's provider network to boost ...

Cloverleaf Bio Raises $33 Million Seed Financing to Advance Novel RNA-Based Cancer Therapeutics Oversubscribed round led by 4BIO Capital includes strategic investment from AbbVie Ventures, Lilly, and ...

BrainChild Bio has raised $116 million in Series A funding to advance its CAR T cell therapies for central nervous system ...

NORTH CHICAGO, IL, UNITED STATES, September 1, 2026 /EINPresswire.com/ — BLR Bio LLC announced new findings demonstrating the potential of its first in class, Yes-Associated Protein (YAP) ...

Cancer is often defined by its complexity: countless mutations, shifting cell populations, and tumors that evolve under ...

This week, I address pushback I received on my Novartis-MorphoSys column. But first, a preview of the expected readout from Gritstone Bio’s neoantigen cancer vaccine study. Before the end of the ...

Noted Indian American cancer researcher to build a model for AI-driven clinical practice and impactful fundamental research.

Brain tumors develop within an organ that changes substantially with age. A new review in Ageing and Cancer Research & ...

Where you live has a relationship to your odds of getting cancer and surviving cancer. Epidemiologists studying this link they see in the data have focused on so-called social determinants of health — ...

Some breast cancer types are more likely than others to recur. Researchers have known this for more than a decade. But they have long wondered why. "How did those tumor types arise?" said Christina ...